BRIEF-CCC Intelligent Solutions Announces The Acquisition of EvolutionIQ-February 2024-www.financetom.com

BRIEF-CCC Intelligent Solutions Announces The Acquisition of EvolutionIQ

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

BRIEF-CCC Intelligent Solutions Announces The Acquisition of EvolutionIQ

Dec 20, 2024 4:58 AM

Dec 20 (Reuters) - CCC Intelligent Solutions Holdings

Inc ( CCCS ):

* CCC INTELLIGENT SOLUTIONS HOLDINGS ( CCCS ): CO'S UNIT SIGNED

DEFINITIVE

AGREEMENT TO ACQUIRE EVOLUTIONIQ

* CCC INTELLIGENT SOLUTIONS HOLDINGS ( CCCS ): PROPOSED DEAL FOR FOR

$730

MILLION

Source text:

Further company coverage:

Previous page： Next page： Republican state AGs raise concerns about Union Pacific deal for Norfolk Southern

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Nov 14, 2025

...

Republican state AGs raise concerns about Union Pacific deal for Norfolk Southern

Nov 14, 2025

WASHINGTON, Nov 14 (Reuters) - A group of nine Republican state attorneys general on Friday raised competition concerns about Union Pacific's ( UNP ) plan to buy smaller rival Norfolk Southern ( NSC ) in an $85 billion deal to create the first U.S. coast-to-coast freight rail operator. The officials, led by Tennessee Attorney General Jonathan Skrmetti and Kansas Attorney...

Israel's Entera Bio Q3 net loss widens

Nov 14, 2025

Overview * Entera Bio reports Q3 2025 net loss of $3.2 mln, with increased operating expenses Outlook * Cash reserves expected to support operations through mid-2026 Result Drivers * Research and development expenses were $1.6 million for the three months ended September 30, 2025, compared to $1.5 million for the same period in 2024, an increase of $0.1 million. Key...

CASI Pharmaceuticals Q3 revenue drops 60%, net loss widens

Nov 14, 2025

Overview * CASI Q3 revenue falls 60% yr/yr due to estimated goods returns for EVOMELA * Net loss for Q3 2025 increased to $10.9 mln from $8.4 mln last year * Company appeals Nasdaq delisting determination, seeking extension to regain compliance Outlook * CASI plans to complete China business divestiture by Q2 2026 * Company to present CID-103 study results...